CellPhenomics

CELLphenomics is a functional precision medicine company that uses automated technology to conduct drug sensitivity screening on fresh primary patient PD3D samples. At CELLphenomics, we utilize this cutting-edge technology to determine which types of novel drugs and drug combinations may be beneficial for future solid tumor patients, such as those with triple-negative breast cancer (TNBC), colorectal cancer (CRC), and non-small cell lung cancer (NSCLC).